Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries
<strong>Background: </strong>Correct diagnosis of maturity-onset diabetes of the young (MODY), which is often misdiagnosed as Type 1 or 2 diabetes, is important for providing appropriate treatment. <strong>Materials & Methods: </strong>A diabetes model was adapted to Hun...
Main Authors: | Szilberhorn, L, Zelei, T, Vellekoop, H, Huygens, S, Versteegh, M, Mölken, MR-V, Koleva-Kolarova, R, Wordsworth, S, Tsiachristas, A, Nagy, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Future Medicine
2023
|
Similar Items
-
Budget impact and transferability of cost–effectiveness of DPYD testing in metastatic breast cancer in three health systems
by: Koleva-Kolarova, R, et al.
Published: (2023) -
Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation
by: Koleva-Kolarova, R, et al.
Published: (2023) -
Guidance for the harmonisation and improvement of economic evaluations of personalised medicine
by: Vellekoop, H, et al.
Published: (2021) -
Cost-effectiveness analysis of treating patients with ntrk-positive cancer with the histology-independent therapy entrectinib
by: Huygens, S, et al.
Published: (2022) -
Financing and reimbursement models for personalised medicine: A systematic review to identify current models and future options
by: Koleva-Kolarova, R, et al.
Published: (2022)